Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 49.76M P/E - EPS this Y - Ern Qtrly Grth -
Income -27.16M Forward P/E -1.77 EPS next Y - 50D Avg Chg 3.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -24.00%
Dividend N/A Price/Book 0.98 EPS next 5Y - 52W High Chg -56.00%
Recommedations - Quick Ratio 7.03 Shares Outstanding 18.60M 52W Low Chg 24.00%
Insider Own 11.81% ROA -28.18% Shares Float 14.51M Beta 1.00
Inst Own 8.93% ROE -53.23% Shares Shorted/Prior 261.46K/149.89K Price 2.68
Gross Margin - Profit Margin - Avg. Volume 22,056 Target Price 12.00
Oper. Margin - Earnings Date Apr 1 Volume 32,271 Change -0.20%
About Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. The company has a collaboration agreement with BeiGene to evaluate the safety and efficacy of Allocetra in combination with tislelizumab, an anti-PD-1 immune checkpoint inhibitor for the treatment of patients with advanced-stage solid tumors. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel.

Enlivex Therapeutics Ltd. News
03/22/24 Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
02/26/24 Enlivex Receives Regulatory Authorization From Israel’s Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis
02/21/24 Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals
02/07/24 Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method
01/17/24 Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis
12/20/23 Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis
12/12/23 Is Enlivex Therapeutics (NASDAQ:ENLV) In A Good Position To Deliver On Growth Plans?
11/21/23 MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer
09/07/23 Enlivex to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08/02/23 Enlivex Announces Peer-Reviewed Publication in Frontiers in Immunology of Clinical Data Details Resolution of Acute Respiratory Distress Syndrome (ARDS) from two Phase I/II Trials Evaluating Allocetra in Patients with COVID-19
07/31/23 Enlivex Announces Dosing of First Patient Under The Amended Protocol Of Its Phase II trial Evaluating Allocetra™ In Patients With Sepsis
06/26/23 Enlivex Announces First Quarter 2023 Financial Results and Provides a Business Update
06/06/23 Enlivex to Present at the 2023 Jefferies Healthcare Conference
05/31/23 Enlivex Selected for an Elevator Pitch Presentation and two additional Poster Presentations at the 2023 Annual Meeting of the International Society for Cell & Gene Therapy
05/08/23 Enlivex Announces Issuance of European Patent Covering the Use of Allocetra™ to Prevent Cytokine Release Syndrome (CRS) Resulting from CAR T-Cell Therapy
04/20/23 We Think Enlivex Therapeutics (NASDAQ:ENLV) Needs To Drive Business Growth Carefully
04/19/23 Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Use of Allocetra™ in Patients Receiving CAR T-Cell Therapy
04/17/23 Enlivex Appoints Andrew Singer to its Board of Directors
04/14/23 Analysts At H.C. Wainwright & Co. Set 12-Month Target Of $15 Per Share For ENLV Thanks To High Profile Collaboration Agreement, Multiple Ongoing Clinical Trials
04/12/23 Enlivex, Beigene Collaborate To Test A New Combination Treatment To Fight Advanced-Stage Solid Tumors
ENLV Chatroom

User Image INTS915 Posted - 5 hours ago

$ENLV , will see...

User Image Kain_C64 Posted - 6 hours ago

$ENLV Dear bears, The CEO has successfully sold a previous company to Pfizer and he maintains a relationship with them to this day. If the results are good Pfizer bucks are gonna gobble this up one way or another. Being bearish could be very expensive. We will find out soon enough who was right.

User Image jacksonjohn7500 Posted - 7 hours ago

$ENLV @INTS915 you two are both bears… you are slow, aren’t you 🫢

User Image jacksonjohn7500 Posted - 7 hours ago

$ENLV I like to stuff soggy pancakes into my underwear!

User Image INTS915 Posted - 7 hours ago

$ENLV , why are you posting 7 years old articles ?

User Image INTS915 Posted - 7 hours ago

$ENLV , covering my 7k short @ 0.70 cents soon.

User Image rockystar996 Posted - 9 hours ago

$ENLV can anyone tell me mode of action after engulfing by macrophage how it programme or neutralize the macrophage can not find anybody post it . Thanks

User Image rockystar996 Posted - 10 hours ago

$ENLV Bio pharma king adam feurestein says Do not buy israeli biopharma stock they run scam positive results https://www.biospace.com/article/unique-why-investors-should-avoid-israeli-biotechs-like-the-plague/

User Image INTS915 Posted - 12 hours ago

$ENLV , data in Q1 2024 mean aftermarket today or tomorrow pre market.

User Image HK416 Posted - 12 hours ago

$ENLV Very good point. Perfect reason for you not to buy. I couldn't care less if they didn't buy, I bought a ton. LOL

User Image rockystar996 Posted - 13 hours ago

$ENLV anyone let me know why insiders dont buy in last 2 years even stock price was in one dollar range?

User Image Nicks_pics Posted - 13 hours ago

$ENLV Someone quietly loading with enough algo power to control the price. Be nice if they let us move into the $5-6's before results though.

User Image furzah Posted - 16 hours ago

@jacksonjohn750 i think you are bearish. I give you one important point. Why was not the study terminate early because of something bad? You know Sepsis is life threating. Every subject which received Allocetra could die. Why is $ENLV Allocetra allow to be finished?

User Image jacksonjohn750 Posted - 17 hours ago

$ENLV the results will be shocking!!

User Image furzah Posted - 18 hours ago

$ENLV i stay calm. Happy Easten! PS, i wish me that the Easter Bunny brings 120 human survived and the hospitalization rate is under 10 days.

User Image Kain_C64 Posted - 1 day ago

$ENLV Let’s hope we get a cure for sepsis so we can start saving lives!

User Image MrSteve13 Posted - 1 day ago

$TTOO I may buy $ENLV but, no way I’m selling $TTOO! https://stocktwits.com/jacksonjohn750/message/567530753

User Image jacksonjohn750 Posted - 1 day ago

@MrSteve13 sell and buy $ENLV

User Image jacksonjohn750 Posted - 1 day ago

$ENLV Are you all ready??? We are almost there!

User Image gurubashix Posted - 1 day ago

$ENLV DISGUSTING PRICE ACTION , cant have a tiny momentom, yikes

User Image NeverShort Posted - 2 days ago

@LXP What's OTS version? I just recall that $ENLV said they shifted to frozen Allocetra.

User Image NeverShort Posted - 2 days ago

@Kain_C64 Where did $ENLV CEO show his confidence?

User Image NeverShort Posted - 2 days ago

@INTS915 $ENLV is a one-trick pony. Either it works or doesn't. But I am betting it does. Phase-1 couldn't have been 100% success if the drug doesn't work. I am only concerned that they had to shift to Frozen Alloectra mid-way as that has a better shelf life. Just hoping it is equally effective as nover-frozen Allocetra.

User Image INTS915 Posted - 2 days ago

$ENLV , be careful here. If the trial fails, this will dip below. $ 1.00.

User Image bcarp Posted - 2 days ago

$ENLV I think there will be one more leg up before the announcement. Maybe into the 5 or 6 area. Seems like the likely target before the news.

User Image Kain_C64 Posted - 3 days ago

$ENLV CEO showing major confidence. His confidence is a strong flex!

User Image gurubashix Posted - 3 days ago

$ENLV יאללה בית"ר, מחר היא ב4.70 עד סוף השבוע ב5

User Image LXP Posted - 3 days ago

$ENLV can anyone remind me how Enlivek determined equivalence for the OTS version of Allocetra? I recall the PR when they stated they made the transition but details escape me

User Image bcarp Posted - 3 days ago

$ENLV I really love how Orwin says, only ENLV knows how to reprogram macrophages. I dont know if its true, or if it will work, but he fills me with confidence. lol

User Image can8232 Posted - 3 days ago

$ENLV שואפים גבוה יותר!!!

Analyst Ratings
HC Wainwright & Co. Buy Sep 25, 23
HC Wainwright & Co. Buy Aug 1, 23
HC Wainwright & Co. Buy Apr 24, 23
HC Wainwright & Co. Buy Apr 5, 23
HC Wainwright & Co. Buy Feb 24, 23
HC Wainwright & Co. Buy May 2, 22
HC Wainwright & Co. Buy Jan 9, 20
Rodman & Renshaw Buy Jan 28, 16
Roth Capital Buy Jun 16, 15